Increased expression of toll-like receptors by monocytes and natural killer cells in anca-associated vasculitis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Tadema, Henko ^a   Abdulahad, Wayel H ^a   Stegeman, Coen A ^a   Kallenberg, Cees G M ^a   Heeringa, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYTOKINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; NEUTROPHIL CYTOPLASMIC ANTIBODY; TOLL LIKE RECEPTOR;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; EX VIVO STUDY; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; NATURAL KILLER CELL; PROTEIN EXPRESSION; REMISSION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; AGED; FEMALE; MALE; METABOLISM; MIDDLE AGED; TUMOR CELL CULTURE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MONOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TUMOR CELLS, CULTURED;

EID: 80052482366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024315     Document Type: Article

References (52)

1. Kallenberg CG, Heeringa P, Stegeman CA, (2006) Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2: 661-670.
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192.
3. Kallenberg CG, Tadema H, (2008) Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "autoimmunity and infection". Autoimmun Rev 8: 29-32.
4. Csernok E, Lamprecht P, Gross WL, (2010) Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 22: 43-48.
5. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, et al. (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120: 12-17.
6. Zycinska K, Wardyn KA, Zielonka TM, Demkow U, Traburzynski MS, (2008) Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis. J Physiol Pharmacol 59 (Suppl 6): 825-831.
7. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG, (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 335: 16-20.
8. Stegeman CA, Tervaert JW, Kallenberg CG, (1997) Co-trimoxazole and Wegener's granulomatosis: more than a coincidence? Nephrol Dial Transplant 12: 652-655.
9. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
10. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531-4537.
11. Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, et al. (2008) Human lymphatic endothelial cells express multiple functional TLRs. J Immunol 180: 3399-3405.
12. Hadley JS, Wang JE, Foster SJ, Thiemermann C, Hinds CJ, (2005) Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling. Infect Immun 73: 7613-7619.
13. Sabroe I, Dower SK, Whyte MK, (2005) The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 41 (Suppl 7): S421-S426.
14. Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, et al. (2007) TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 37: 2205-2213.
15. Hurtado PR, Jeffs L, Nitschke J, Patel M, Sarvestani G, et al. (2008) CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol 9: 34.
16. Huggins J, Pellegrin T, Felgar RE, Wei C, Brown M, et al. (2007) CpG DNA activation and plasma-cell differentiation of. Blood 109: 1611-1619.
17. Isnardi I, Ng YS, Srdanovic I, Motaghedi R, Rudchenko S, et al. (2008) IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29: 746-757.
18. Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderon Gomez E, et al. (2008) TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 180: 4763-4773.
19. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
20. Stenzel W, Soltek S, Sanchez-Ruiz M, Akira S, Miletic H, et al. (2008) Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 172: 132-145.
21. Takeuchi O, Hoshino K, Akira S, (2000) Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165: 5392-5396.
22. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
23. Capolunghi F, Rosado MM, Cascioli S, Girolami E, Bordasco S, et al. (2010) Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. Rheumatology (Oxford) 49: 2281-2289.
24. Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CGM, et al. (2010) Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxford) 50: 689-696.
25. Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, et al. (2008) Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 58: 3684-3692.
26. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, et al. (2007) Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 56: 2957-2967.
27. Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, et al. (2006) Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 54: 3601-3611.
28. Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL, (2007) Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37: 3582-3586.
29. Deng J, Ma-Krupa W, Gewirtz AT, Younge BR, Goronzy JJ, et al. (2009) Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res 104: 488-495.
30. Uehara A, Sato T, Iwashiro A, Yokota S, (2009) PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2. Diagn Pathol 4: 23.
31. Hattar K, van Burck S, Bickenbach A, Grandel U, Maus U, et al. (2005) Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation. J Leukoc Biol 78: 992-1000.
32. Huugen D, Xiao H, van EA, Falk RJ, Peutz-Kootstra CJ, et al. (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167: 47-58.
33. Summers SA, van der Veen BS, O'Sullivan KM, Gan PY, Ooi JD, et al. (2010) Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 78: 1263-1274.
34. Summers SA, Steinmetz OM, Gan PY, Ooi JD, Odobasic D, et al. (2010) TLR2 induces Th17 myeloperoxidase autoimmunity, while TLR9 drives Th1 autoimmunity. Arthritis Rheum 63: 1124-1135.
35. Tervaert JW, Mulder L, Stegeman C, Elema J, Huitema M, et al. (1993) Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 52: 115-120.
36. Lidar M, Lipschitz N, Langevitz P, Shoenfeld Y, (2009) The infectious etiology of vasculitis. Autoimmunity 42: 432-438.
37. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ, (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406-17409.
38. Muller Kobold AC, Kallenberg CG, Tervaert JW, (1999) Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 58: 237-245.
39. Wikman A, Lundahl J, Jacobson SH, (2008) Sustained monocyte activation in clinical remission of systemic vasculitis. Inflammation 31: 384-390.
40. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536-3542.
41. Lauzon NM, Mian F, MacKenzie R, Ashkar AA, (2006) The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 241: 102-112.
42. Farag SS, Caligiuri MA, (2006) Human natural killer cell development and biology. Blood Rev 20: 123-137.
43. Small CL, McCormick S, Gill N, Kugathasan K, Santosuosso M, et al. (2008) NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J Immunol 180: 5558-5568.
44. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
45. Bernasconi NL, Onai N, Lanzavecchia A, (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
46. Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG, (2006) Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 70: 938-947.
47. Salomao R, Martins PS, Brunialti MK, Fernandes Mda L, Martos LS, et al. (2008) TLR signaling pathway in patients with sepsis. Shock 30 (Suppl 1): 73-77.
48. Harter L, Mica L, Stocker R, Trentz O, Keel M, (2004) Increased expression of toll-like receptor-2 and-4 on leukocytes from patients with sepsis. Shock 22: 403-409.
49. Ralston DR, Marsh CB, Lowe MP, Wewers MD, (1997) Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 100: 1416-1424.
50. Falk RJ, Terrell RS, Charles LA, Jennette JC, (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119.
51. Gollapudi P, Yoon JW, Gollapudi S, Pahl MV, Vaziri ND, (2010) Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol 31: 247-254.
52. Myles A, Aggarwal A, (2010) Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology (Oxford) 50: 481-488.